Here are three key notes:
1. The system is a minimally invasive interbody fusion device providing integrated fixation.
2. The system is designed for use in patients with degenerative disc disease at 1 or 2 contiguous levels from L2 to S1.
3. The system is intended for use with bone graft and with supplemental fixation systems.
More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
